Formally known as Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate , PRL-8-53 is a synthetic compound derived from benzoic acid. It was first synthesized in the 1970s by Dr. Nikolaus Hansl at Creighton University. It was classified as a "hypermnesic" drug—a substance hypothesized to enhance memory beyond baseline levels. How It Works: The Mechanism
In many jurisdictions, PRL-8-53 remains unscheduled, meaning it is not a controlled substance, but it is also not approved by the FDA or similar regulatory bodies for medical use. It is primarily handled as a research chemical. Final Thoughts prl 8 53 buy
PRL-8-53 remains an intriguing subject in the field of nootropics. While early data is compelling, the lack of contemporary human trials means that its long-term effects and full safety profile remain unknown. For those interested in cognitive science, it represents a unique chapter in the history of memory research. It was classified as a "hypermnesic" drug—a substance
Subjects who took a small dose saw an increase in their ability to remember lists of words when tested 24 hours later. Final Thoughts PRL-8-53 remains an intriguing subject in